Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Finocchietti

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
BMJ Paediatrics Open|March 22, 2021
Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective reviewValeria Belleudi, Federico Marchetti, Marco Finocchietti, et al.
Recenti Progressi in Medicina|December 17, 2024
Michela Servadio, Valeria Belleudi, Marco Finocchietti, et al.
Toxins|September 27, 2023
Evaluation of Statistical Treatment of Left-Censored Contamination Data: Example Involving Deoxynivalenol Occurrence in Pasta and Pasta Substitute ProductsAlessandro Feraldi, Barbara De Santis, Marco Finocchietti, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical PracticeErsilia Lucenteforte, Marco Finocchietti, Antonio Addis, et al.
Recenti Progressi in Medicina|April 13, 2026
[The regional network for CAR-T therapies in the Lazio Region: a governance model for innovation and sustainability.]Valeria Belleudi, Michela Servadio, Silvia Alessio, et al.
Frontiers in Pharmacology|April 11, 2022
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real PracticeValeria Belleudi, Marco Finocchietti, Filomena Fortinguerra, et al.
Pharmacoepidemiology and Drug Safety|November 28, 2023
Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR studySabrina Giometto, Marco Finocchietti, Olga Paoletti, et al.
Epidemiologia E Prevenzione|July 12, 2024
Incidence and prevalence of Amyotrophic Lateral Sclerosis in three Italian Regions: a study based on health administrative databasesIlaria Bacigalupo, Marco Finocchietti, Olga Paoletti, et al.
Frontiers in Neurology|January 5, 2024
Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in ItalyGiada Crescioli, Marco Finocchietti, Olga Paoletti, et al.
Italian Journal of Pediatrics|March 26, 2024
An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort studyMichela Servadio, Marco Finocchietti, Chiara Vassallo, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
BMJ Paediatrics Open|March 22, 2021
Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective reviewValeria Belleudi, Federico Marchetti, Marco Finocchietti, et al.
Recenti Progressi in Medicina|December 17, 2024
Michela Servadio, Valeria Belleudi, Marco Finocchietti, et al.
Toxins|September 27, 2023
Evaluation of Statistical Treatment of Left-Censored Contamination Data: Example Involving Deoxynivalenol Occurrence in Pasta and Pasta Substitute ProductsAlessandro Feraldi, Barbara De Santis, Marco Finocchietti, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical PracticeErsilia Lucenteforte, Marco Finocchietti, Antonio Addis, et al.
Recenti Progressi in Medicina|April 13, 2026
[The regional network for CAR-T therapies in the Lazio Region: a governance model for innovation and sustainability.]Valeria Belleudi, Michela Servadio, Silvia Alessio, et al.
Frontiers in Pharmacology|April 11, 2022
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real PracticeValeria Belleudi, Marco Finocchietti, Filomena Fortinguerra, et al.
Pharmacoepidemiology and Drug Safety|November 28, 2023
Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR studySabrina Giometto, Marco Finocchietti, Olga Paoletti, et al.
Epidemiologia E Prevenzione|July 12, 2024
Incidence and prevalence of Amyotrophic Lateral Sclerosis in three Italian Regions: a study based on health administrative databasesIlaria Bacigalupo, Marco Finocchietti, Olga Paoletti, et al.
Frontiers in Neurology|January 5, 2024
Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in ItalyGiada Crescioli, Marco Finocchietti, Olga Paoletti, et al.
Italian Journal of Pediatrics|March 26, 2024
An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort studyMichela Servadio, Marco Finocchietti, Chiara Vassallo, et al.
Pageof 3